malondialdehyde has been researched along with Adenoma, Prostatic in 29 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 2 (6.90) | 18.2507 |
2000's | 7 (24.14) | 29.6817 |
2010's | 14 (48.28) | 24.3611 |
2020's | 6 (20.69) | 2.80 |
Authors | Studies |
---|---|
Chen, CW; Hsieh, RH; Lin, YL; Tsai, HH; Yu, PL | 1 |
Higashi, Y; Kamada, S; Kataoka, T; Nagao, Y; Saito, M; Shimizu, S; Shimizu, T | 1 |
Akbar Karami, A; Bakhshpour, M; Haddadi, E; Mehdi Mirhashemi, S; Mohammadi, N; Reza Memarzadeh, M; Sheikhsoleimani, M | 1 |
Kayode, AAA; Kayode, OT; Owolabi, AV | 1 |
Al-Barzinj, RMGT | 1 |
Higashi, Y; Karashima, T; Nagao, Y; Saito, M; Shimizu, S; Shimizu, T | 1 |
Bedir, S; Ebiloglu, T; Eken, A; Erdem, O; Ergin, G; Kaya, E; Ozgok, Y; Zor, M | 1 |
Afolayan, OO; Anunobi, CC; Durojaiye, TE; Ishola, IO; Yemitan, KO | 1 |
Jeon, WY; Lee, MY; Park, E; Seo, CS; Shin, HK; You, S | 1 |
Campolo, M; Cordaro, M; Cuzzocrea, S; Esposito, E; Filippone, A; Paterniti, I; Siracusa, R | 1 |
Aikawa, K; Akaihata, H; Haga, N; Hashimoto, Y; Hata, J; Hoshi, S; Ishibashi, K; Kataoka, M; Koguchi, T; Kojima, Y; Matsuoka, K; Ogawa, S; Sato, Y; Suzuki, O; Yanagida, T | 1 |
Refaie, MMM; Rifaai, RA; Zenhom, NM | 1 |
Honda, M; Kinoshita, Y; Oikawa, R; Saito, M; Sejima, T; Shimizu, S; Tomita, S; Tsounapi, P | 1 |
Almeida, EA; Gobbo, MG; Góes, RM; Pinto-Fochi, ME; Rafacho, A; Ribeiro, DL; Silva, SA; Taboga, SR | 1 |
Abdel-Naim, AB; Ammar, AE; Esmat, A; Guns, ES; Hassona, MD; Tadros, MG | 1 |
Lahouel, M; Lobaccaro, JM; Mabed, D; Zabaiou, N | 1 |
Higashi, Y; Honda, M; Inoue, K; Martin, DT; Nakamura, K; Saito, M; Shimizu, S; Shimizu, T; Tsounapi, P | 1 |
Chen, J; Ruan, JL; Xiong, CM; Zhang, HF | 1 |
Bao, L; Feng, X; Hiroshi, K; Rao, X; Xie, G; Yao, N | 1 |
Arsova-Sarafinovska, Z; Aydin, A; Banev, S; Dimovski, AJ; Dzikova, S; Eken, A; Erdem, O; Georgiev, V; Matevska, N; Ozgök, Y; Petrovski, D; Savaser, A; Sayal, A; Sikole, A; Suturkova, L | 1 |
Bowen, PE; Pajkovic, N; Sharifi, R; Stacewicz-Sapuntzakis, M; van Breemen, RB; Viana, M; Yang, Y; Yuan, L; Zhu, D | 1 |
Ahmed, RS; Banerjee, BD; Datta, SK; Goel, S; Grover, RK; Gupta, S; Kumar, V; Mustafa, M; Singh, S; Yadav, CS | 1 |
Di Pasquale, G; Fraccica, G; Gangemi, S; Merendino, RA; Minciullo, PL; Saija, A; Salvo, F; Tomaino, A | 1 |
Almushatat, AS; McArdle, PA; McMillan, DC; O'Reilly, DS; Sattar, N; Talwar, D; Underwood, MA; Williamson, C | 1 |
Devkota, AK; Halaweish, F; Singh, KK; Singh, YN; Sneeden, DC | 1 |
Aryal, M; Baral, N; Chandra, L; Das, BK; Gautam, N; Lamsal, M; Majhi, S; Pandeya, A; Pandit, R | 1 |
Gonzalez, RM; Jimenez, S; Mas, R; Menendez, R; Molina, V; Oyarzabal, A; Perez, Y | 1 |
Iguchi, H; Ikeuchi, T; Kai, Y; Yoshida, H | 1 |
Bandivdekar, AH; Devasagayam, TP; Hurkadli, KS; Joseph, R; Pradhan, DS; Sheth, AR | 1 |
2 trial(s) available for malondialdehyde and Adenoma, Prostatic
Article | Year |
---|---|
Urtica Dioica Root Extract on Clinical and Biochemical Parameters in Patients with Benign Prostatic Hyperplasia, Randomized Controlled Trial.
Topics: Aged; Aged, 80 and over; C-Reactive Protein; Double-Blind Method; Humans; Iran; Male; Malondialdehyde; Middle Aged; Oxidative Stress; Placebos; Plant Extracts; Plant Roots; Prostatic Hyperplasia; Superoxide Dismutase; Surveys and Questionnaires; Symptom Assessment; Tablets; Urtica dioica | 2020 |
Antioxidant effects of lycopene in African American men with prostate cancer or benign prostate hyperplasia: a randomized, controlled trial.
Topics: Aged; Aged, 80 and over; Antioxidants; Black or African American; Carotenoids; Double-Blind Method; Humans; Lipid Peroxidation; Lycopene; Male; Malondialdehyde; Middle Aged; Oxidative Stress; Prostatic Hyperplasia; Prostatic Neoplasms; Spectrometry, Mass, Matrix-Assisted Laser Desorption-Ionization | 2011 |
27 other study(ies) available for malondialdehyde and Adenoma, Prostatic
Article | Year |
---|---|
Mangosteen pericarp components alleviate progression of prostatic hyperplasia and mitochondrial dysfunction in rats.
Topics: Animals; Body Weight; Diet, High-Fat; Dietary Supplements; Dihydrotestosterone; Disease Models, Animal; Disease Progression; Garcinia mangostana; Male; Malondialdehyde; Mitochondria; Nitric Oxide Synthase Type II; Oxidative Stress; Plant Extracts; Proliferating Cell Nuclear Antigen; Prostate; Prostatic Hyperplasia; Rats; Rats, Inbred F344; Testosterone | 2020 |
Protective effects of tadalafil on prostatic hyperplasia in spontaneously hypertensive rats.
Topics: Animals; Fibroblast Growth Factors; Hypertension; Interleukin-6; Male; Malondialdehyde; Phosphodiesterase 5 Inhibitors; Prostate; Prostatic Hyperplasia; Rats, Inbred SHR; Rats, Inbred WKY; Regional Blood Flow; Tadalafil; Transforming Growth Factor beta1 | 2020 |
Biochemical and histomorphological changes in testosterone propionate-induced benign prostatic hyperplasia in male Wistar rats treated with ketogenic diet.
Topics: Animals; Antioxidants; Biomarkers; Diet, Ketogenic; Disease Models, Animal; Hormones; Lipids; Male; Malondialdehyde; Prostate; Prostate-Specific Antigen; Prostatic Hyperplasia; Rats, Wistar; Testosterone Propionate; Time Factors | 2020 |
Estimation levels of prostate-specific antigen, interleukin-8, oxidative stress and some inflammatory markers in sera of benign prostatic hyperplasia patients who have smoking habits as a risk factor.
Topics: Adult; Aged; Aged, 80 and over; Biomarkers; Case-Control Studies; Humans; Inflammation; Interleukin-8; Kidney; Male; Malondialdehyde; Middle Aged; Oxidative Stress; Prostate-Specific Antigen; Prostatic Hyperplasia; Risk Factors; Smoking; Young Adult | 2020 |
Therapeutic effects of losartan on prostatic hyperplasia in spontaneously hypertensive rats.
Topics: Animals; Antihypertensive Agents; Blood Pressure; Hypertension; Losartan; Male; Malondialdehyde; Oxidative Stress; Prostatic Hyperplasia; Rats; Rats, Inbred SHR; Rats, Inbred WKY | 2021 |
Oxidative stress parameters in patients with prostate cancer, benign prostatic hyperplasia and asymptomatic inflammatory prostatitis: A prospective controlled study.
Topics: Aged; Catalase; Humans; Male; Malondialdehyde; Middle Aged; Oxidative Stress; Prospective Studies; Prostatic Hyperplasia; Prostatic Neoplasms; Prostatitis; Superoxide Dismutase | 2017 |
Potential of Moringa oleifera in the Treatment of Benign Prostate Hyperplasia: Role of Antioxidant Defence Systems.
Topics: Animals; Antioxidants; Catalase; Dose-Response Relationship, Drug; Glutathione; Male; Malondialdehyde; Moringa oleifera; Plant Extracts; Plant Leaves; Prostate; Prostate-Specific Antigen; Prostatic Hyperplasia; Rats; Rats, Sprague-Dawley; Superoxide Dismutase; Testosterone | 2018 |
Paljung-San, a traditional herbal medicine, attenuates benign prostatic hyperplasia in vitro and in vivo.
Topics: Animals; Anti-Inflammatory Agents; Antioxidants; Cell Line; Cell Proliferation; Cell Survival; Cyclin D1; Cyclooxygenase 2; Dihydrotestosterone; Dinoprostone; Glutathione Reductase; Humans; Male; Malondialdehyde; Medicine, Traditional; Oxidative Stress; Phytotherapy; Plant Extracts; Proliferating Cell Nuclear Antigen; Prostatic Hyperplasia; Rats, Sprague-Dawley; Reactive Oxygen Species | 2018 |
Effects of different natural extracts in an experimental model of benign prostatic hyperplasia (BPH).
Topics: Ajuga; Animals; Apoptosis; Cholestenone 5 alpha-Reductase; Cyclooxygenase 2; Dihydrotestosterone; Dinoprostone; Disease Models, Animal; Epilobium; Male; Malondialdehyde; NF-kappa B; NF-KappaB Inhibitor alpha; Nitric Oxide Synthase Type II; Phytotherapy; Plant Extracts; Prostate; Prostatic Hyperplasia; Rats, Sprague-Dawley; Selenium; Serenoa; Testosterone Propionate | 2018 |
The association between local atherosclerosis of the prostatic artery and benign prostatic enlargement in humans: Putative mechanism of chronic ischemia for prostatic enlargement.
Topics: Aged; Atherosclerosis; Fibroblast Growth Factor 2; Humans; Hypoxia-Inducible Factor 1, alpha Subunit; Ischemia; Lower Urinary Tract Symptoms; Male; Malondialdehyde; Middle Aged; Prostate; Prostatic Hyperplasia; Transforming Growth Factor beta1 | 2018 |
Role of PPAR-α agonist fenofibrate in the treatment of induced benign prostatic hyperplasia with dysplastic changes in rats.
Topics: Animals; Antioxidants; Dihydrotestosterone; Fenofibrate; Glutathione Peroxidase; Male; Malondialdehyde; PPAR alpha; Prostate; Prostate-Specific Antigen; Prostatic Hyperplasia; Rats; Rats, Wistar; Superoxide Dismutase; Testosterone | 2018 |
Prostatic ischemia induces ventral prostatic hyperplasia in the SHR; possible mechanism of development of BPH.
Topics: Actins; Animals; Biomarkers; Blood Pressure; Dihydrotestosterone; Enzyme-Linked Immunosorbent Assay; Fibroblast Growth Factor 2; Hypertension; Hypoxia-Inducible Factor 1, alpha Subunit; Ischemia; Male; Malondialdehyde; Oxidative Stress; Prostate; Prostatic Hyperplasia; Rats; Rats, Inbred SHR; Rats, Inbred WKY; Regional Blood Flow; Transforming Growth Factor beta1 | 2014 |
Prostate hyperplasia caused by long-term obesity is characterized by high deposition of extracellular matrix and increased content of MMP-9 and VEGF.
Topics: Animals; Biomarkers; Blood Glucose; Catalase; Cell Proliferation; Cellular Microenvironment; Disease Models, Animal; Extracellular Matrix; Glutathione Transferase; Insulin; Male; Malondialdehyde; Matrix Metalloproteinase 9; Obesity; Oxidation-Reduction; Prostate; Prostatic Hyperplasia; Rats, Wistar; Receptors, Androgen; Risk Factors; Stromal Cells; Testosterone; Time Factors; Up-Regulation; Vascular Endothelial Growth Factor A | 2015 |
The effect of pomegranate fruit extract on testosterone-induced BPH in rats.
Topics: Animals; Apoptosis; Catalase; Cyclooxygenase 2; Glutathione; Immunohistochemistry; In Situ Nick-End Labeling; Ki-67 Antigen; Lythraceae; Male; Malondialdehyde; Nitric Oxide Synthase Type II; Organ Size; Plant Extracts; Prostatic Hyperplasia; Random Allocation; Rats; Rats, Sprague-Dawley; Superoxide Dismutase; Testosterone | 2015 |
Oxidative stress in benign prostate hyperplasia.
Topics: Aged; Aged, 80 and over; Catalase; Glutathione; Glutathione Peroxidase; Glutathione Transferase; Humans; Male; Malondialdehyde; Middle Aged; Oxidative Stress; Prostate; Prostatic Hyperplasia; Superoxide Dismutase | 2016 |
Effect of Silodosin, an Alpha1A-Adrenoceptor Antagonist, on Ventral Prostatic Hyperplasia in the Spontaneously Hypertensive Rat.
Topics: Actins; Adrenergic alpha-1 Receptor Antagonists; Animals; Chemokine CXCL1; Fibroblast Growth Factor 2; Indoles; Interleukin-6; Male; Malondialdehyde; Prostate; Prostatic Hyperplasia; Rats; Rats, Inbred SHR; Receptors, Adrenergic, alpha-1; Regional Blood Flow; Transforming Growth Factor beta1; Tumor Necrosis Factor-alpha | 2015 |
Inhibitory effect of diosgenin on experimentally induced benign prostatic hyperplasia in rats.
Topics: Animals; Apoptosis; bcl-2-Associated X Protein; Diosgenin; Glutathione Peroxidase; Male; Malondialdehyde; Oxidative Stress; Prostate; Prostate-Specific Antigen; Prostatic Hyperplasia; Proto-Oncogene Proteins c-bcl-2; Rats; Rats, Sprague-Dawley; Superoxide Dismutase; Tumor Suppressor Protein p53 | 2016 |
[Effect of fenghuaqianqingcha on experimentally induced prostatic hyperplasia in mice].
Topics: Animals; Cholestenone 5 alpha-Reductase; Disease Models, Animal; Drug Combinations; Drugs, Chinese Herbal; Glutathione; Male; Malondialdehyde; Mice; Oxidative Stress; Plants, Medicinal; Pollen; Prostate; Prostatic Hyperplasia; Testosterone; Testosterone Propionate | 2008 |
Increased oxidative/nitrosative stress and decreased antioxidant enzyme activities in prostate cancer.
Topics: Aged; Antioxidants; Catalase; Glutathione Peroxidase; Humans; Male; Malondialdehyde; Middle Aged; Nitrates; Nitrites; Oxidative Stress; Prostatic Hyperplasia; Prostatic Neoplasms; Republic of North Macedonia; Superoxide Dismutase; Turkey | 2009 |
Association of GSTM1 and GSTT1 polymorphism with lipid peroxidation in benign prostate hyperplasia and prostate cancer: a pilot study.
Topics: Aged; Biomarkers; Cross-Sectional Studies; Genotype; Glutathione Transferase; Humans; Lipid Peroxidation; Male; Malondialdehyde; Middle Aged; Oxidative Stress; Pilot Projects; Polymerase Chain Reaction; Polymorphism, Genetic; Prostatic Hyperplasia; Prostatic Neoplasms; Sequence Deletion; Smoking; Tobacco, Smokeless | 2011 |
Malondialdehyde in benign prostate hypertrophy: a useful marker?
Topics: Aged; Biomarkers; Humans; Male; Malondialdehyde; Middle Aged; Oxidative Stress; Prostate-Specific Antigen; Prostatic Hyperplasia | 2003 |
Vitamin antioxidants, lipid peroxidation and the systemic inflammatory response in patients with prostate cancer.
Topics: Aged; Aged, 80 and over; Antineoplastic Agents, Hormonal; Antioxidants; Carotenoids; Case-Control Studies; Disease Progression; Humans; Inflammation; Lipid Peroxidation; Male; Malondialdehyde; Middle Aged; Neoplasm Metastasis; Neoplasm Staging; Oxidative Stress; Prostatic Hyperplasia; Prostatic Neoplasms | 2006 |
Hepatotoxicity potential of saw palmetto (Serenoa repens) in rats.
Topics: Animals; Chemical and Drug Induced Liver Injury; Dose-Response Relationship, Drug; Fruit; Lipid Peroxidation; Liver; Male; Malondialdehyde; Phytotherapy; Plant Extracts; Prostatic Hyperplasia; Rats; Rats, Sprague-Dawley; Serenoa | 2007 |
Oxidative stress in benign prostate hyperplasia.
Topics: Age Factors; Aged; Ascorbic Acid; Case-Control Studies; Humans; Lipid Peroxidation; Male; Malondialdehyde; Middle Aged; Oxidative Stress; Prostatic Hyperplasia; Tocopherols | 2007 |
Ex vivo antioxidant effects of D-004, a lipid extract from Roystonea regia fruits, on rat prostate tissue.
Topics: Administration, Oral; Animals; Antioxidants; Arecaceae; Dose-Response Relationship, Drug; Male; Malondialdehyde; Plant Extracts; Prostate; Prostatic Hyperplasia; Rats; Rats, Wistar | 2008 |
[Influence of anti-androgen therapy for prostatic hypertrophy on lipid metabolism].
Topics: Aged; Aged, 80 and over; Allylestrenol; Androgen Antagonists; Chlormadinone Acetate; Gestonorone Caproate; Humans; Lipid Metabolism; Lipids; Lipoproteins, HDL; Male; Malondialdehyde; Middle Aged; Nandrolone; Prostatic Hyperplasia | 1994 |
Modulation of lipid peroxidation in human spermatozoa and human prostate by prostatic inhibin.
Topics: Dose-Response Relationship, Drug; Humans; Inhibins; Lipid Peroxidation; Male; Malondialdehyde; Prostate; Prostatic Hyperplasia; Spermatozoa | 1990 |